The decision to test for allergy should be based on first-hand knowledge gained by an individual history and physical examination. The results of allergy testing must be interpreted in light of these findings. The decision to treat with immunotherapy should be based not just on the results of skin or in vitro testing, but on a first-hand knowledge of the patients status. If immunotherapy is chosen, it should be administered under the supervision of a physician who has received proper training in the administration and adjustment of immunotherapy, and concomitant pharmacotherapy. The selection of antigens and initial dosage, escalation of dosage, alterations in dosage (due to increased exposure, local or systemic reaction, complicating infections, etc.), and length of therapy should be the responsibility of a properly-trained physician who is in contact with the patient.
Submitted for Review 4/13/1995
Submitted for Review 3/1/1998
Important Disclaimer Notice (Updated 7/31/14)
Position statements are approved by the American Academy of Otolaryngology—Head and Neck Surgery or Foundation (AAO-HNS/F) Boards of Directors and are typically generated from AAO-HNS/F committees. Once approved by the Academy or Foundation Board of Directors, they become official position statements and are added to the existing position statement library. In no sense do they represent a standard of care. The applicability of position statements, as guidance for a procedure, must be determined by the responsible physician in light of all the circumstances presented by the individual patient. Adherence to these clinical position statements will not ensure successful treatment in every situation. As with all AAO-HNS/F guidance, this position statement should not be deemed inclusive of all proper treatment decisions or methods of care, nor exclusive of other treatment decisions or methods of care reasonably directed to obtaining the same results. Position statements are not intended to and should not be treated as legal, medical, or business advice.